Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples